Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine Hebsgaard

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Dermatology and Therapy|January 18, 2021
Calcipotriol/Betamethasone Dipropionate Foam Inhibits Th17 Cytokine Secretion and Improves Epidermal Barrier Markers in a Human Th17 Skin Inflammation ModelPaola Lovato, Li Jiang, Josephine Hebsgaard, et al.
Experimental Dermatology|August 2, 2020
Development and characterization of a human Th17-driven ex vivo skin inflammation modelClaire Jardet, Anthony David, Emilie Braun, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2025
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesisSophia Wasserer, Thomas Litman, Josephine Hebsgaard, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Dermatology and Therapy|January 18, 2021
Calcipotriol/Betamethasone Dipropionate Foam Inhibits Th17 Cytokine Secretion and Improves Epidermal Barrier Markers in a Human Th17 Skin Inflammation ModelPaola Lovato, Li Jiang, Josephine Hebsgaard, et al.
Experimental Dermatology|August 2, 2020
Development and characterization of a human Th17-driven ex vivo skin inflammation modelClaire Jardet, Anthony David, Emilie Braun, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2025
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesisSophia Wasserer, Thomas Litman, Josephine Hebsgaard, et al.
Pageof 1